OVERVIEWASNC’s Nuclear Cardiology Choosing Wisely® Challenge is a competition designed to help our members:
- Share your most creative practice innovations and technology solutions
- Support the growth of your specialty
- Earn cash prizes and advance your career
- Implementation of appropriate use
- Optimizing radiation dose
- Enhanced communications with referring clinicians.
ASNC will award three prizes based on the most innovative, creative ideas and implementable plans:
1st Prize - $3,000
2nd Prize - $2,500
3rd Prize - $1,000
The three finalists will be invited to present their solutions to a live viewing audience and an evaluation panel at ASNC2019 in Chicago, Ill. All parties submitting agree to pay their own expenses to ASNC19 and underwrite any related presentation materials, should their submission be selected for presentation.
ASNC will promote the finalists in the ASNC2019 Final Program, in the Journal of Nuclear Cardiology, in media releases, and in ASNC member communications including ASNC’s social media channels.
Participants may be asked at a later date to provide a brief summary and/or video describing their solution, which will be posted publicly on ASNC’s Nuclear Cardiology Choosing Wisely® Challenge portal.
Thanks to our sponsor Bracco Diagnostics Inc.
Incomplete submissions will not be accepted.
- Submissions can be from a single individual, although ASNC strongly encourages innovators to work in teams of a variety of stakeholders.
- Only one submission per individual/team is permitted.
- The Challenge is open to fellows, trainees, technologists, and physicians, with preference given to those less than 10 years out of training, who are participating as a team, as long as at least one team member is an ASNC member. If interested participants are not a current ASNC member, they are encouraged to join.
- Submissions are encouraged to be patient centered, team-based projects—e.g., projects delivered by a partnership between industry and an academic lab, a private practice office and a software developer, or a team of researchers working with a lab(s) to demonstrate a novel idea.
- Submissions may be in the concept phase or already in practice. However, they must present an original idea or offer an innovative adaptation or approach to a current application, protocol or procedure that relates directly to Nuclear Cardiology. Case reports will not be considered.
- All submissions should have evidence of a fully thought out concept or partial execution of concept. Such evidence may include research findings, documentation of time or cost savings, documentation of improved patient safety, a prototype of a program or technology, or any other relevant information.
- Submissions should include approaches and projects that support the Choosing Wisely objectives within one of the following core areas:
- Development of communication channels with referring physicians to improve rate of appropriate referrals
- Implementation and use of Appropriate Use Criteria and new patient/test selection technologies which demonstrates reduced rates of inappropriate imaging in asymptomatic, low risk patients
- Innovative implementation of quality improvement measures and patient safety tools and resources (i.e. ImageGuide Registry, ASNC guidelines) to enhance clinical outcomes and improve patient safety via appropriate test and protocol selection and criteria; radiation dose optimization, etc.
- A submission proposal, not to exceed 1900 words, should contain:
- List of team members, noting who is an ASNC member
- Introduction (outline the problem)
- Solution or proposed solution
- Outcome measures, such as research findings
- What was the most interesting or surprising thing you learned in the process?
- What were / are the major roadblocks or difficulties you faced during the process?
- How could this process or project change the field of nuclear cardiology?
- Ideas of how this project could be implemented elsewhere – scalability
Awards are based on the most innovative, creative ideas and implementable plans.
- The Phase 1 Evaluation Panel, announced at a later date, will include a variety of qualified individuals from the ASNC membership.
- This panel will be responsible for evaluating all components of each submission.
- Judges will select up to 10 semi-finalists and three finalists.
- Initial evaluation criteria will be developed by this panel and categories may include originality, strength of design, data, scalability/ease of implementation in other practices, and outcomes measurement.
- Submissions are private and only seen by relevant ASNC staff and judges. If a submission is chosen as a semi-finalist, additional material may be requested for further consideration.
- The evaluation panel reserves the right to provide mentorship to promising submissions even if not selected for a monetary prize.
- The live evaluation panel may include some or all members of the Phase 1 Evaluation Panel, as well as additional qualified individuals from various medical and non-medical backgrounds.
- After the three finalists’ presentations at ASNC2019, the finalists will be ranked by a combination of votes by the live evaluation panel and the audience.
Evaluation Panel decisions and winner are final, binding, and shall not be subject to appeal or change.
703-459-2555 ext. 2553
Thanks to those that took the 2018 challenge!
Winning submissions support ASNC’s goal of encouraging the right test for the right patient at the right time and were presented at ASNC2018.
Feasibility & Initial Results of a Decision to Test Algorithm Using DASI in Operable Lung Cancer Patients - Christopher Johnson, MD, Nadine Gauthier, MD, FRCP; Angeline Law, MD, FRCP; Eugene Leung, MD, FRCP; Calvin Thompson, MD, FRCP
Systematic Cardiac Risk Assessment with PET/CT Myocardial Perfusion Imaging using an Objective Risk Score Approach - David Min, MD;Steve Mason, PA-C; Jon-David Ethington, PA-C; Raymond McCubrey, MStat; Kent Meredith, MD